$AMGN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMGEN INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AMGEN INC. Get notifications about new insider transactions in AMGEN INC for free.
Page: < prev 1 2 3 4 5 6 7 ... 27 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 07 2019 | AMGN | AMGEN INC | Graham Jonathan P | SVP, Gen. Counsel & ... | Option Exercise | A | 177.31 | 27,568 | 4,888,082 | 27,568 | |
May 07 2019 | AMGN | AMGEN INC | Graham Jonathan P | SVP, Gen. Counsel & ... | Grant | A | 0.00 | 3,158 | 0 | 49,204 | 46 K to 49.2 K (+6.86 %) |
May 07 2019 | AMGN | AMGEN INC | Graham Jonathan P | SVP, Gen. Counsel & ... | Payment of Exercise | F | 176.50 | 523 | 92,310 | 46,046 | 46.6 K to 46 K (-1.12 %) |
May 07 2019 | AMGN | AMGEN INC | Gordon Murdo | EVP Global Commerci ... | Option Exercise | A | 177.31 | 39,382 | 6,982,822 | 39,382 | |
May 07 2019 | AMGN | AMGEN INC | Gordon Murdo | EVP Global Commerci ... | Grant | A | 0.00 | 4,511 | 0 | 39,236 | 34.7 K to 39.2 K (+12.99 %) |
May 07 2019 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Option Exercise | A | 177.31 | 137,840 | 24,440,410 | 137,840 | |
May 07 2019 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Grant | A | 0.00 | 15,791 | 0 | 467,392 | 451.6 K to 467.4 K (+3.50 %) |
May 07 2019 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Payment of Exercise | F | 176.50 | 2,379 | 419,894 | 451,601 | 454 K to 451.6 K (-0.52 %) |
May 07 2019 | AMGN | AMGEN INC | Williams R Sanders | Director | Grant | A | 0.00 | 1,127 | 0 | 6,263 | 5.1 K to 6.3 K (+21.94 %) |
May 07 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Grant | A | 0.00 | 1,127 | 0 | 14,219 | 13.1 K to 14.2 K (+8.61 %) |
May 07 2019 | AMGN | AMGEN INC | Kullman Ellen Jamison | Director | Grant | A | 0.00 | 1,301 | 0 | 4,845 | 3.5 K to 4.8 K (+36.71 %) |
May 07 2019 | AMGN | AMGEN INC | Jacks Tyler | Director | Grant | A | 0.00 | 1,127 | 0 | 10,212 | 9.1 K to 10.2 K (+12.41 %) |
May 07 2019 | AMGN | AMGEN INC | HOLLEY CHARLES M | Director | Grant | A | 0.00 | 1,228 | 0 | 2,783 | 1.6 K to 2.8 K (+78.97 %) |
May 07 2019 | AMGN | AMGEN INC | HERRINGER FRANK C | Director | Grant | A | 0.00 | 1,127 | 0 | 35,522 | 34.4 K to 35.5 K (+3.28 %) |
May 07 2019 | AMGN | AMGEN INC | HENDERSON REBECCA M | Director | Grant | A | 0.00 | 1,127 | 0 | 16,610 | 15.5 K to 16.6 K (+7.28 %) |
May 07 2019 | AMGN | AMGEN INC | Hassan Fred | Director | Grant | A | 0.00 | 1,127 | 0 | 8,345 | 7.2 K to 8.3 K (+15.61 %) |
May 07 2019 | AMGN | AMGEN INC | Garland Greg C. | Director | Grant | A | 0.00 | 1,127 | 0 | 8,178 | 7.1 K to 8.2 K (+15.98 %) |
May 07 2019 | AMGN | AMGEN INC | ECKERT ROBERT | Director | Grant | A | 0.00 | 1,127 | 0 | 10,878 | 9.8 K to 10.9 K (+11.56 %) |
May 07 2019 | AMGN | AMGEN INC | Druker Brian | Director | Grant | A | 0.00 | 1,127 | 0 | 1,819 | 692 to 1.8 K (+162.86 %) |
May 07 2019 | AMGN | AMGEN INC | Austin Wanda M | Director | Grant | A | 0.00 | 1,127 | 0 | 2,348 | 1.2 K to 2.3 K (+92.30 %) |
May 03 2019 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Payment of Exercise | F | 179.32 | 171 | 30,664 | 46,046 | 46.2 K to 46 K (-0.37 %) |
May 03 2019 | AMGN | AMGEN INC | Santos Esteban | EVP, Operations | Payment of Exercise | F | 179.32 | 597 | 107,056 | 35,564 | 36.2 K to 35.6 K (-1.65 %) |
May 03 2019 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Payment of Exercise | F | 179.32 | 851 | 152,604 | 31,738 | 32.6 K to 31.7 K (-2.61 %) |
May 03 2019 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Payment of Exercise | F | 179.32 | 163 | 29,230 | 32,859 | 33 K to 32.9 K (-0.49 %) |
May 03 2019 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Payment of Exercise | F | 179.32 | 164 | 29,409 | 26,149 | 26.3 K to 26.1 K (-0.62 %) |
May 03 2019 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Payment of Exercise | F | 179.32 | 746 | 133,775 | 54,187 | 54.9 K to 54.2 K (-1.36 %) |
May 03 2019 | AMGN | AMGEN INC | Johnston Lori A | SVP, HR | Payment of Exercise | F | 179.32 | 341 | 61,149 | 16,505 | 16.8 K to 16.5 K (-2.02 %) |
May 03 2019 | AMGN | AMGEN INC | Graham Jonathan P | SVP, Gen. Counsel & ... | Payment of Exercise | F | 179.32 | 532 | 95,400 | 46,569 | 47.1 K to 46.6 K (-1.13 %) |
May 03 2019 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Payment of Exercise | F | 179.32 | 2,433 | 436,293 | 453,980 | 456.4 K to 454 K (-0.53 %) |
May 03 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Option Exercise | M | 54.71 | 2,000 | 109,420 | 12,000 | |
May 03 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Sell | S | 175.73 | 2,000 | 351,460 | 13,092 | 15.1 K to 13.1 K (-13.25 %) |
May 03 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Buy | M | 54.71 | 2,000 | 109,420 | 15,092 | 13.1 K to 15.1 K (+15.28 %) |
Apr 03 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Option Exercise | M | 54.71 | 2,000 | 109,420 | 14,000 | |
Apr 03 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Sell | S | 193.18 | 2,000 | 386,360 | 13,092 | 15.1 K to 13.1 K (-13.25 %) |
Apr 03 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Buy | M | 54.71 | 2,000 | 109,420 | 15,092 | 13.1 K to 15.1 K (+15.28 %) |
Mar 25 2019 | AMGN | AMGEN INC | Santos Esteban | EVP, Operations | Payment of Exercise | F | 191.89 | 1,838 | 352,694 | 36,161 | 38 K to 36.2 K (-4.84 %) |
Mar 25 2019 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Payment of Exercise | F | 191.89 | 1,769 | 339,453 | 32,752 | 34.5 K to 32.8 K (-5.12 %) |
Mar 25 2019 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Payment of Exercise | F | 191.89 | 1,509 | 289,562 | 46,217 | 47.7 K to 46.2 K (-3.16 %) |
Mar 25 2019 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Payment of Exercise | F | 191.89 | 1,515 | 290,713 | 26,313 | 27.8 K to 26.3 K (-5.44 %) |
Mar 25 2019 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Payment of Exercise | F | 191.89 | 8,040 | 1,542,796 | 54,933 | 63 K to 54.9 K (-12.77 %) |
Mar 25 2019 | AMGN | AMGEN INC | Graham Jonathan P | SVP, Gen. Counsel & ... | Payment of Exercise | F | 191.89 | 5,283 | 1,013,755 | 47,101 | 52.4 K to 47.1 K (-10.09 %) |
Mar 25 2019 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Payment of Exercise | F | 191.89 | 25,268 | 4,848,677 | 456,413 | 481.7 K to 456.4 K (-5.25 %) |
Mar 08 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Option Exercise | M | 54.71 | 2,000 | 109,420 | 14,988 | |
Mar 08 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Sell | S | 188.88 | 2,000 | 377,760 | 12,988 | 15 K to 13 K (-13.34 %) |
Mar 08 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Buy | M | 54.71 | 2,000 | 109,420 | 14,988 | 13 K to 15 K (+15.40 %) |
Mar 08 2019 | AMGN | AMGEN INC | Santos Esteban | EVP, Operations | Grant | A | 0.00 | 3,676 | 0 | 37,843 | 34.2 K to 37.8 K (+10.76 %) |
Mar 08 2019 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Grant | A | 0.00 | 3,676 | 0 | 34,324 | 30.6 K to 34.3 K (+11.99 %) |
Mar 08 2019 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Grant | A | 0.00 | 3,676 | 0 | 47,674 | 44 K to 47.7 K (+8.35 %) |
Mar 08 2019 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Grant | A | 0.00 | 3,676 | 0 | 27,777 | 24.1 K to 27.8 K (+15.25 %) |
Mar 08 2019 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Grant | A | 0.00 | 16,086 | 0 | 62,746 | 46.7 K to 62.7 K (+34.47 %) |
Mar 08 2019 | AMGN | AMGEN INC | Graham Jonathan P | SVP, Gen. Counsel & ... | Grant | A | 0.00 | 10,570 | 0 | 52,123 | 41.6 K to 52.1 K (+25.44 %) |
Mar 08 2019 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Grant | A | 0.00 | 50,557 | 0 | 480,956 | 430.4 K to 481 K (+11.75 %) |
Feb 11 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Option Exercise | M | 54.71 | 2,000 | 109,420 | 18,000 | |
Feb 11 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Sell | S | 190.00 | 2,000 | 380,000 | 12,988 | 15 K to 13 K (-13.34 %) |
Feb 11 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Buy | M | 54.71 | 2,000 | 109,420 | 14,988 | 13 K to 15 K (+15.40 %) |
Feb 11 2019 | AMGN | AMGEN INC | Johnston Lori A | SVP, HR | Payment of Exercise | F | 190.76 | 454 | 86,605 | 16,794 | 17.2 K to 16.8 K (-2.63 %) |
Feb 11 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Option Exercise | M | 54.71 | 2,000 | 109,420 | 18,000 | |
Feb 11 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Sell | S | 190.00 | 2,000 | 380,000 | 12,988 | 15 K to 13 K (-13.34 %) |
Feb 11 2019 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Buy | M | 54.71 | 2,000 | 109,420 | 14,988 | 13 K to 15 K (+15.40 %) |
Feb 11 2019 | AMGN | AMGEN INC | Johnston Lori A | SVP, HR | Payment of Exercise | F | 190.76 | 454 | 86,605 | 16,794 | 17.2 K to 16.8 K (-2.63 %) |
Feb 05 2019 | AMGN | AMGEN INC | Kullman Ellen Jamison | Director | Grant | A | 0.00 | 187 | 0 | 3,519 | 3.3 K to 3.5 K (+5.61 %) |
Feb 05 2019 | AMGN | AMGEN INC | HOLLEY CHARLES M | Director | Grant | A | 0.00 | 106 | 0 | 1,543 | 1.4 K to 1.5 K (+7.38 %) |
Feb 01 2019 | AMGN | AMGEN INC | Santos Esteban | EVP, Operations | Payment of Exercise | F | 192.11 | 142 | 27,280 | 34,700 | 34.8 K to 34.7 K (-0.41 %) |
Feb 01 2019 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Payment of Exercise | F | 192.11 | 115 | 22,093 | 30,648 | 30.8 K to 30.6 K (-0.37 %) |
Feb 01 2019 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Payment of Exercise | F | 192.11 | 162 | 31,122 | 43,998 | 44.2 K to 44 K (-0.37 %) |
Feb 01 2019 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Payment of Exercise | F | 192.11 | 117 | 22,477 | 24,101 | 24.2 K to 24.1 K (-0.48 %) |
Feb 01 2019 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Payment of Exercise | F | 192.11 | 528 | 101,434 | 46,660 | 47.2 K to 46.7 K (-1.12 %) |
Feb 01 2019 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Payment of Exercise | F | 192.11 | 1,625 | 312,179 | 430,399 | 432 K to 430.4 K (-0.38 %) |
Dec 10 2018 | AMGN | AMGEN INC | Jacks Tyler | Director | Option Exercise | M | 82.60 | 20,000 | 1,652,000 | 0 | |
Dec 10 2018 | AMGN | AMGEN INC | Jacks Tyler | Director | Sell | S | 195.41 | 20,000 | 3,908,232 | 8,979 | 29 K to 9 K (-69.02 %) |
Dec 10 2018 | AMGN | AMGEN INC | Jacks Tyler | Director | Buy | M | 82.60 | 20,000 | 1,652,000 | 28,979 | 9 K to 29 K (+222.74 %) |
Dec 03 2018 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Option Exercise | M | 54.69 | 6,500 | 355,485 | 0 | |
Dec 03 2018 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Option Exercise | M | 54.69 | 6,500 | 355,485 | 0 | |
Dec 03 2018 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Payment of Exercise | F | 202.37 | 4,109 | 831,538 | 41,019 | 45.1 K to 41 K (-9.11 %) |
Dec 03 2018 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Payment of Exercise | F | 202.37 | 4,109 | 831,538 | 41,019 | 45.1 K to 41 K (-9.11 %) |
Dec 03 2018 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Buy | M | 54.69 | 6,500 | 355,485 | 45,128 | 38.6 K to 45.1 K (+16.83 %) |
Dec 03 2018 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Buy | M | 54.69 | 6,500 | 355,485 | 45,128 | 38.6 K to 45.1 K (+16.83 %) |
Dec 03 2018 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Option Exercise | M | 54.69 | 1,777 | 97,184 | 0 | |
Dec 03 2018 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Option Exercise | M | 54.69 | 1,777 | 97,184 | 0 | |
Dec 03 2018 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Sell | S | 202.88 | 1,777 | 360,520 | 21,313 | 23.1 K to 21.3 K (-7.70 %) |
Dec 03 2018 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Sell | S | 202.88 | 1,777 | 360,520 | 21,313 | 23.1 K to 21.3 K (-7.70 %) |
Dec 03 2018 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Buy | M | 54.69 | 1,777 | 97,184 | 23,090 | 21.3 K to 23.1 K (+8.34 %) |
Dec 03 2018 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Buy | M | 54.69 | 1,777 | 97,184 | 23,090 | 21.3 K to 23.1 K (+8.34 %) |
Nov 06 2018 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Grant | A | 0.00 | 12,830 | 0 | 30,618 | 17.8 K to 30.6 K (+72.13 %) |
Nov 06 2018 | AMGN | AMGEN INC | Kullman Ellen Jamison | Director | Grant | A | 0.00 | 149 | 0 | 3,312 | 3.2 K to 3.3 K (+4.71 %) |
Nov 06 2018 | AMGN | AMGEN INC | HOLLEY CHARLES M | Director | Grant | A | 0.00 | 93 | 0 | 1,427 | 1.3 K to 1.4 K (+6.97 %) |
Nov 06 2018 | AMGN | AMGEN INC | Gordon Murdo | EVP Global Commerci ... | Grant | A | 0.00 | 34,213 | 0 | 34,213 | 0 to 34.2 K |
Aug 14 2018 | AMGN | AMGEN INC | HENDERSON REBECCA M | Director | Option Exercise | M | 63.11 | 3,000 | 189,330 | 0 | |
Aug 14 2018 | AMGN | AMGEN INC | HENDERSON REBECCA M | Director | Payment of Exercise | F | 193.97 | 977 | 189,509 | 15,220 | 16.2 K to 15.2 K (-6.03 %) |
Aug 14 2018 | AMGN | AMGEN INC | HENDERSON REBECCA M | Director | Buy | M | 63.11 | 3,000 | 189,330 | 16,197 | 13.2 K to 16.2 K (+22.73 %) |
Aug 14 2018 | AMGN | AMGEN INC | HENDERSON REBECCA M | Director | Option Exercise | M | 63.11 | 3,000 | 189,330 | 0 | |
Aug 14 2018 | AMGN | AMGEN INC | HENDERSON REBECCA M | Director | Payment of Exercise | F | 193.97 | 977 | 189,509 | 15,220 | 16.2 K to 15.2 K (-6.03 %) |
Aug 14 2018 | AMGN | AMGEN INC | HENDERSON REBECCA M | Director | Buy | M | 63.11 | 3,000 | 189,330 | 16,197 | 13.2 K to 16.2 K (+22.73 %) |
Aug 06 2018 | AMGN | AMGEN INC | Graham Jonathan P | SVP, Gen. Counsel & ... | Payment of Exercise | F | 197.99 | 6,586 | 1,303,962 | 41,256 | 47.8 K to 41.3 K (-13.77 %) |
Aug 02 2018 | AMGN | AMGEN INC | Santos Esteban | EVP, Operations | Payment of Exercise | F | 196.55 | 1,982 | 389,562 | 34,654 | 36.6 K to 34.7 K (-5.41 %) |
Aug 02 2018 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Payment of Exercise | F | 196.55 | 7,382 | 1,450,932 | 52,202 | 59.6 K to 52.2 K (-12.39 %) |
Aug 02 2018 | AMGN | AMGEN INC | Kullman Ellen Jamison | Director | Grant | A | 0.00 | 152 | 0 | 3,144 | 3 K to 3.1 K (+5.08 %) |
Aug 02 2018 | AMGN | AMGEN INC | HOLLEY CHARLES M | Director | Grant | A | 0.00 | 89 | 0 | 2,585 | 2.5 K to 2.6 K (+3.57 %) |
Aug 02 2018 | AMGN | AMGEN INC | Druker Brian | Director | Grant | A | 0.00 | 678 | 0 | 678 | 0 to 678 |
Jul 16 2018 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Sell | S | 195.71 | 1,525 | 298,458 | 56,082 | 57.6 K to 56.1 K (-2.65 %) |
Jun 25 2018 | AMGN | AMGEN INC | Onyx Therapeutics, Inc. | 10% Owner | Option Exercise | C | 0.00 | 1,121,384 | 0 | 0 | |
Jun 25 2018 | AMGN | AMGEN INC | Onyx Therapeutics, Inc. | 10% Owner | Buy | C | 0.00 | 1,121,384 | 0 | 1,121,384 | 0 to 1.1 M |
Jun 12 2018 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Sell | S | 184.27 | 1,525 | 281,012 | 57,510 | 59 K to 57.5 K (-2.58 %) |
May 15 2018 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Option Exercise | M | 54.71 | 15,000 | 820,650 | 0 | |
May 15 2018 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Payment of Exercise | F | 170.77 | 9,860 | 1,683,792 | 41,706 | 51.6 K to 41.7 K (-19.12 %) |
May 15 2018 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Buy | M | 54.71 | 15,000 | 820,650 | 51,566 | 36.6 K to 51.6 K (+41.02 %) |
May 15 2018 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Sell | S | 174.10 | 1,525 | 265,503 | 59,035 | 60.6 K to 59 K (-2.52 %) |
May 07 2018 | AMGN | AMGEN INC | Santos Esteban | EVP, Operations | Payment of Exercise | F | 169.43 | 178 | 30,159 | 36,466 | 36.6 K to 36.5 K (-0.49 %) |
May 07 2018 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Payment of Exercise | F | 169.43 | 178 | 30,159 | 36,566 | 36.7 K to 36.6 K (-0.48 %) |
May 07 2018 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Payment of Exercise | F | 169.43 | 169 | 28,634 | 24,156 | 24.3 K to 24.2 K (-0.69 %) |
May 07 2018 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Payment of Exercise | F | 169.43 | 773 | 130,969 | 59,382 | 60.2 K to 59.4 K (-1.29 %) |
May 07 2018 | AMGN | AMGEN INC | HOOPER ANTHONY C | EVP, Global Commerc ... | Payment of Exercise | F | 169.43 | 883 | 149,607 | 215,147 | 216 K to 215.1 K (-0.41 %) |
May 07 2018 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Payment of Exercise | F | 169.43 | 736 | 124,700 | 60,560 | 61.3 K to 60.6 K (-1.20 %) |
May 07 2018 | AMGN | AMGEN INC | Graham Jonathan P | SVP, Gen. Counsel & ... | Payment of Exercise | F | 169.43 | 390 | 66,078 | 47,366 | 47.8 K to 47.4 K (-0.82 %) |
May 07 2018 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Payment of Exercise | F | 169.43 | 2,312 | 391,722 | 431,101 | 433.4 K to 431.1 K (-0.53 %) |
May 01 2018 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Option Exercise | A | 177.46 | 6,940 | 1,231,572 | 6,940 | |
May 01 2018 | AMGN | AMGEN INC | Patton Cynthia M | SVP & CCO | Grant | A | 0.00 | 901 | 0 | 24,325 | 23.4 K to 24.3 K (+3.85 %) |
May 01 2018 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Option Exercise | A | 177.46 | 34,702 | 6,158,217 | 34,702 | |
May 01 2018 | AMGN | AMGEN INC | Meline David W | EVP & CFO | Grant | A | 0.00 | 4,508 | 0 | 60,155 | 55.6 K to 60.2 K (+8.10 %) |
May 01 2018 | AMGN | AMGEN INC | Johnston Lori A | SVP, HR | Option Exercise | A | 177.46 | 15,615 | 2,771,038 | 15,615 | |
May 01 2018 | AMGN | AMGEN INC | Johnston Lori A | SVP, HR | Grant | A | 0.00 | 2,028 | 0 | 17,085 | 15.1 K to 17.1 K (+13.47 %) |
May 01 2018 | AMGN | AMGEN INC | HOOPER ANTHONY C | EVP, Global Commerc ... | Option Exercise | A | 177.46 | 34,702 | 6,158,217 | 34,702 | |
May 01 2018 | AMGN | AMGEN INC | HOOPER ANTHONY C | EVP, Global Commerc ... | Grant | A | 0.00 | 4,508 | 0 | 216,030 | 211.5 K to 216 K (+2.13 %) |
May 01 2018 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Option Exercise | A | 177.46 | 34,702 | 6,158,217 | 34,702 | |
May 01 2018 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Grant | A | 0.00 | 4,508 | 0 | 61,296 | 56.8 K to 61.3 K (+7.94 %) |
May 01 2018 | AMGN | AMGEN INC | Graham Jonathan P | SVP, Gen. Counsel & ... | Option Exercise | A | 177.46 | 24,291 | 4,310,681 | 24,291 | |
May 01 2018 | AMGN | AMGEN INC | Graham Jonathan P | SVP, Gen. Counsel & ... | Grant | A | 0.00 | 3,155 | 0 | 47,756 | 44.6 K to 47.8 K (+7.07 %) |
May 01 2018 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Option Exercise | A | 177.46 | 108,444 | 19,244,472 | 108,444 | |
May 01 2018 | AMGN | AMGEN INC | Bradway Robert A | Chairman, CEO and P ... | Grant | A | 0.00 | 14,087 | 0 | 433,413 | 419.3 K to 433.4 K (+3.36 %) |
May 01 2018 | AMGN | AMGEN INC | Williams R Sanders | Director | Grant | A | 0.00 | 1,127 | 0 | 5,136 | 4 K to 5.1 K (+28.11 %) |
May 01 2018 | AMGN | AMGEN INC | SUGAR RONALD D | Director | Grant | A | 0.00 | 1,127 | 0 | 12,721 | 11.6 K to 12.7 K (+9.72 %) |
May 01 2018 | AMGN | AMGEN INC | Kullman Ellen Jamison | Director | Grant | A | 0.00 | 1,301 | 0 | 2,974 | 1.7 K to 3 K (+77.76 %) |
May 01 2018 | AMGN | AMGEN INC | Jacks Tyler | Director | Grant | A | 0.00 | 1,127 | 0 | 8,881 | 7.8 K to 8.9 K (+14.53 %) |
May 01 2018 | AMGN | AMGEN INC | HOLLEY CHARLES M | Director | Grant | A | 0.00 | 1,228 | 0 | 2,488 | 1.3 K to 2.5 K (+97.46 %) |
May 01 2018 | AMGN | AMGEN INC | HERRINGER FRANK C | Director | Grant | A | 0.00 | 1,127 | 0 | 50,875 | 49.7 K to 50.9 K (+2.27 %) |
May 01 2018 | AMGN | AMGEN INC | HENDERSON REBECCA M | Director | Grant | A | 0.00 | 1,127 | 0 | 13,111 | 12 K to 13.1 K (+9.40 %) |
May 01 2018 | AMGN | AMGEN INC | Hassan Fred | Director | Grant | A | 0.00 | 1,127 | 0 | 7,218 | 6.1 K to 7.2 K (+18.50 %) |
May 01 2018 | AMGN | AMGEN INC | Garland Greg C. | Director | Grant | A | 0.00 | 1,127 | 0 | 7,051 | 5.9 K to 7.1 K (+19.02 %) |
May 01 2018 | AMGN | AMGEN INC | ECKERT ROBERT | Director | Grant | A | 0.00 | 1,127 | 0 | 9,488 | 8.4 K to 9.5 K (+13.48 %) |
May 01 2018 | AMGN | AMGEN INC | de Carbonnel Francois | Director | Payment of Exercise | F | 175.37 | 260 | 45,596 | 16,426 | 16.7 K to 16.4 K (-1.56 %) |
May 01 2018 | AMGN | AMGEN INC | de Carbonnel Francois | Director | Grant | A | 0.00 | 1,127 | 0 | 16,686 | 15.6 K to 16.7 K (+7.24 %) |
May 01 2018 | AMGN | AMGEN INC | BALTIMORE DAVID | Director | Grant | A | 0.00 | 1,127 | 0 | 32,286 | 31.2 K to 32.3 K (+3.62 %) |
May 01 2018 | AMGN | AMGEN INC | Austin Wanda M | Director | Grant | A | 0.00 | 1,127 | 0 | 1,221 | 94 to 1.2 K (+1,198.94 %) |
May 01 2018 | AMGN | AMGEN INC | Santos Esteban | EVP, Operations | Option Exercise | A | 177.46 | 24,291 | 4,310,681 | 24,291 | |
May 01 2018 | AMGN | AMGEN INC | Santos Esteban | EVP, Operations | Grant | A | 0.00 | 3,155 | 0 | 36,644 | 33.5 K to 36.6 K (+9.42 %) |
May 01 2018 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Option Exercise | A | 177.46 | 7,374 | 1,308,590 | 7,374 | |
May 01 2018 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Grant | A | 0.00 | 957 | 0 | 36,744 | 35.8 K to 36.7 K (+2.67 %) |
Apr 26 2018 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Payment of Exercise | F | 171.94 | 217 | 37,311 | 35,787 | 36 K to 35.8 K (-0.60 %) |
Apr 16 2018 | AMGN | AMGEN INC | Harper Sean E | EVP, Research & Dev ... | Sell | S | 172.68 | 1,525 | 263,337 | 56,788 | 58.3 K to 56.8 K (-2.62 %) |
Mar 27 2018 | AMGN | AMGEN INC | Piacquad David | SVP, Business Devel ... | Payment of Exercise | F | 176.08 | 1,519 | 267,466 | 36,004 | 37.5 K to 36 K (-4.05 %) |